chrisvoncsefalvay/vaers-outcomes huggingface dataset:
little bit congestion; tested positive for covid-19; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Apr-2021 and was forwarded to Moderna on 22-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and NASAL CONGESTION (little bit congestion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for covid-19). On an unknown date, the patient experienced NASAL CONGESTION (little bit congestion). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for covid-19) and NASAL CONGESTION (little bit congestion) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Mar-2021, SARS-CoV-2 test: positive On APR 3, the patient received the result of covid-19 PCR test, which was positive. and negative Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
pt stated felt woozy immed p/vax;colon remained good;p/leaving devel diff breathing, rapid heart beat-head feels swollen glands swollen;
Hives all over body, swelling, severe itching. Steroid did nothing, moved to antihistamines which temporarily reduce rash. 6 months of the same results.
Full body itching without appearance of rash; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 03Apr2021 at 13:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously took latex (MANUFACTURER UNKNOWN), experienced latex allergy and pecans (MANUFACTURER UNKNOWN), experienced food allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:45, the patient experienced full body itching without appearance of rash. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event full body itching was recovered on an unknown date in Apr2021.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Pt fully vaccinated with Pfizer: dose 1 1/5/21 and dose 2 1/26/21.  Pt. reports COVID symptoms of cough, sore throat, runny nose, chills, headache, and fatigue starting 9/2/21. Tested positive on 9/2/21.
The pt experienced acute onset facial swelling, erythema, scleral lesions on arms, treated with Benadryl. The pt also had periorbital swelling which progressed to the point where the pt was unable to open her eyes. Swelling improved promptly with administration of Benadryl.
Adult dose of Havrix was inadvertently given to pediatric patient in her left vastus lateralis; no adverse side effects were experienced over monitoring time; mother was notified of possible "flu like symptoms" that may occur due to the dosing error
This spontaneous report as received from a healthcare professional via field representative referred to a female patient of unknown age. On an unknown date the patient was vaccinated with PNEUMOVAX23 (lot#, dose/frequency, route and duration were unspecified). It was indicated that patient ended up with something that looked like cellulitis after being administered PNEUMOVAX23. The outcome and causality were unknown. This is one of several report that received from the same source. Additional information has been requested.
Rash developed at injection site roughly 1 day after vaccination. Around 2 in x 1 in red and inflamed.  Painful to touch.
This case was reported by a consumer via call center representative and described the occurrence of cold in a 72-year-old male patient who received SHINGRIX. Concomitant products included amlodipine and Baby Aspirin. On 11th April 2018 16:00, the patient received the 1st dose of SHINGRIX (intramuscular). On 11th April 2018, less than a day after receiving SHINGRIX, the patient experienced cold. On 12th April 2018, the patient experienced myalgia, flushing, fatigue, headache and shivering. On an unknown date, the outcome of the cold, myalgia, flushing, fatigue, headache and shivering were not recovered/not resolved. The reporter considered the cold, myalgia, flushing, fatigue, headache and shivering to be probably related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the left deltoid. On 11th April 2018, the patient felt cold later the night of the vaccination and the next morning he developed shivering and other side effects.
Non sustained VT, frequent PVCs, couplets, Bigeminy, Atrial tachycardia and premature atrial complexes were all noted via EKG and subsequent holter monitoring which were new for the patient (no ectopy/arrhythmias noted by EKGs or Holters dating back to 2008
Day after, I had a fever of 102, aches and fatigue, and a bad headache that triggered my migraine headache.  I also was feeling nauseous and bloated.  That bloated feeling in my stomach hasn't left for a week now so I went into to Urgent Care to get checked out.  The doctor said most likely it's an effect from the booster.  If it doesn't get better in 2 weeks, I was told to follow up with my primary doctor.
Left arm "sun burn" and general joint aches. 70yo and was not billed for PNEUMOVAX so dispensed. Now find patient did get PNEUMOVAX when turned 65. Administered 3/26/13 more than 5 years ago. Patient states on day 3 the reaction is improving. No expected treatment.
Child became very irritable, had grunting respirations and twitching of her lower extremities approximately 24 hrs after receiving initial vaccination. Child was seen in the emergency room.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 72-year-old male patient who received Shingrix for prophylaxis. On 8th September 2018 18:30, the patient received the 1st dose of Shingrix (subcutaneous). On 8th September 2018, unknown after receiving Shingrix, the patient experienced intramuscular formulation administered by other route. In September 2018, the patient experienced injection site pain and injection site erythema. On an unknown date, the outcome of the injection site pain was recovering/resolving and the outcome of the injection site erythema was recovered/resolved and the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the injection site pain and injection site erythema to be related to Shingrix. Additional details were reported as follows: The reporter reported this case for her fiancé. The pharmacist pinched a small area on the back of the arm and that where the vaccine administered. The patient experienced redness at the injection site, which was 3 inches by 2 inches in area. The reporter stated that, the patient was administered a dose of Shingrix vaccine subcutaneously in left arm, which led to inappropriate route of administration. The patient gave permission to contact her health care provider. No further details were provided. This case was link with case US2018165440, reported by the same reporter.
Symptoms - ?body aches, chills, fever (Tmax 101.9).  Patient took 1000 mg tylenol at 07:45.  Temp 100.9 at time of call.  Patient reports hx of lupus. Last day of work and shift ? next shift on Sunday (2/7)?  Home remedies? -   rest and tylenol Any improvement? - mild Recommendation?  Patient reports she called MD on call at clinic and advised to contact vaccine support line for recommendations.  Patient educated to contact PCP for further recommendations/medical advice, Patient verbalized back understanding.  Patient educated to continue to monitor symptoms at home and to take Tylenol as directed in the Medical Directive and to increase fluid intake.  Patient educated to manage her symptoms and to adhere to the Illness in the Workplace Policy.  Patient verbalized back understanding and denied further questions at this time.
flu symptoms 5 or 6 hours after the first injection.; soreness in his injection site left shoulde; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (flu symptoms 5 or 6 hours after the first injection.) and VACCINATION SITE PAIN (soreness in his injection site left shoulde) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu symptoms 5 or 6 hours after the first injection.) and VACCINATION SITE PAIN (soreness in his injection site left shoulde). At the time of the report, INFLUENZA LIKE ILLNESS (flu symptoms 5 or 6 hours after the first injection.) and VACCINATION SITE PAIN (soreness in his injection site left shoulde) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication was reported by the reporter.  Patient experienced flu symptoms 5 or 6 hours after the first injection.  No treatment medication was reported by the reporter.   This case was linked to MOD-2022-528199, MOD-2022-528209 (Patient Link).
above inj site-swelling in muscle to size of small apple-initially very hard, hot, red;swelling subsided on 5OCT97;red area approx 3"x2" went away on 7OCT97;
Blood clot in leg. Began as pain and skin discoloration in leg, eventually went to emergency room on 07Apr2021 and diagnosed with ultrasound. Treated with Xarelto, ongoing. Acute right lower extremity superficial thrombophlebitis noted in the greater saphenous (above knee). This superficial thrombophlebitis extends more than 10 cm in length. It does not extend into the deep system but is about 1.3 cm from the origin of the common femoral vein.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-066083 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pain in elbow, hip and knee occasionally. Arm sore for few days then other s/s began. No treatment taken.
Developed a fever and vomiting on 07/14/2014 and by 07/18/2014 has rash on top of buttocks.
pt recv vax; pain at site of inject; pt cont to suffer pain in arm 5 wk p/ vax;
Patient reports shortness of breath, fevers, chills, diffuse myalgias along with right-sided back and chest pain since receiving the COVID vaccine. Symptoms began a few hours after receiving the vaccine. She reports localized pain to the injection site but denies redness or swelling. She reports she had fevers for 2 to 3 days, highest being of 101. She presented to the ED on 4/10/21 because of worsening shortness of breath with mild cough and pain in her back.  This is exertional along with pleuritic. She reports she has overall improved from the myalgias but is generally not feeling well and continues to have dyspnea.
LOWER BACK PAIN; MUSCLE PAIN IN LEGS; FATIGUE; HEADACHE; This spontaneous report received from a patient concerned a 35 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the patient experienced lower back pain. On 07-APR-2021, the patient experienced muscle pain in legs. On 07-APR-2021, the patient experienced fatigue. On 07-APR-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle pain in legs, lower back pain, fatigue, and headache. This report was non-serious.
Information has been received from a Registered Nurse concerning 3 females who were vaccinated with Gardasil and fainted. The patients recovered completely after a few minutes. Additional information has been requested.
HBV sAb titer <8.0 on 9/27/2021 labs. Administered Heplisav-B vaccine series per manufactuer recommendations (dose #1 on 12/15/2021 and dose #2 on 1/26/2022). Checked HBV sAb titer again on 6/28/2022 and level remains below threshold of 8.0. Patient did not achieve HBV immunity (so the AE is vaccine failure). Will reach out to patient to see if he is willing to receive another series of HBV vaccination.
SkinRash face was hot, face redness/sclera redness, Narrative:  took benadryl prn and sx went away in approx. 3hrs.
Pain in left arm and shoulder since the first vaccine.  Now pain has become debilitating.  I am not able to use my arm.
Fatigue, elevated temp, congestion, coughing on 7/9. Tested positive for Covid19 on 7/10. Prescribed Paxlovid . On day 3, symptoms improving.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 29 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 06Dec2021 13:00 (Lot number: FJ8762) at the age of 29 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Comirnaty (Dose 2, Batch/Lot Number: EW1071), administration date: 26Apr2021, when the patient was 28 years old, for COVID-19 immunization; Comirnaty (Dose 1, Batch/Lot Number: EW0150), administration date: 05Apr2021, when the patient was 28 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 06Dec2021 13:00, outcome "unknown", described as "booster"; VACCINATION SITE PAIN (non-serious) with onset 06Dec2021 15:00, outcome "not recovered", described as "Pain around the injection site on the left arm, which was the site of administration". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: No other vaccine in four-weeks. No other medications in two-weeks. No covid prior vaccination. No covid tested post vaccination. No Known allergies.  No follow-up attempts are possible. No further information is expected.
Bullseye redness burning and itching at injection sight   Around 2-21/2 inches in circumference
Very bad sore arm 24 hours and counting. Chills for 3 hours starting 10 hours after injection. Hour 12 after injection 101.1 fahrenheit fever lasting about 2 hours. Better with one 500mg Tylenol. 20 hours later woke up with excruciating lower abdominal and lower back pain radiating to thighs. Still ongoing
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown ages and gender. No information on patients medical history or concurrent conditions was provided. On an unknown dates, the patients were vaccinated with improperly stored dose of PROQUAD (Merck) (dose, dose number, frequency, route of administration, lot# and expiration date were not reported). No information on patients concomitant medication was provided. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
Extremely ill; Difficulty breathing; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (Extremely ill) and DYSPNOEA (Difficulty breathing) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Extremely ill) and DYSPNOEA (Difficulty breathing). At the time of the report, ILLNESS (Extremely ill) and DYSPNOEA (Difficulty breathing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported No treatment Drug was reported.  Company Comment: Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
I work out at a gym 3 times a week so am in good health. Last night I was very cold while sleeping. I like my house cool and the A/C runs 24 hrs per day. I'm never cold. I was cold last night and had to dig out a comforter to put over the sheet that I normally use. Never really got warm. This morning I have no energy and am lethargic. Arm is a bit sore but that is nothing. Just feel "hazy". No energy. Probably not that unusual reaction. When I had the first shot a few months ago I never experienced any adverse effects. Probably just my body doing its thing with the vaccine but thought I better report it anyhow. I am not in dire straits. Probably will take a couple of days to get back to normal.
Given children's Motrin at 10:30 AM and at 7:30 on 08/08/01. At 3:00 AM on 08/09/01, this child had a fever of 103 (oral), a fine rash on his body and vomited. The mother reports fever gone in 48 hours, rash gone in 5 days. Her doctor told her he felt it was not from the vaccine.
I had my vaccination on 04/27/2022. I had fatigue on 04/28/2022 and it lasted for 7 days. On 05/04/2022 I started to experience an increase in heartrate. This lasted for a couple minutes subside and then continue throughout the day for a couple of weeks. I went to Cardiology. My cardiologist prescribed me metoprolol. I haven't had any more episodes since 05/2022 but I am still taking the medication.
Thirty minutes after receiving vaccine the patient developed a pinpoint rash on bilateral forearms and tightness in the throat. The patient became anxious.
Little dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Little dizziness) and HEADACHE (Headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced DIZZINESS (Little dizziness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing from 01-Mar-2021 at a dose of unknown. At the time of the report, DIZZINESS (Little dizziness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications included unspecified medicine for blood pressure and other unspecified medications.   Reporter did not allow further contact
Client was given a Tdap on 03/24/2009.  When entering data on MCIR, imm clerk noted that Tdap was given per private provider on 11/08/2008.  That Tdap was not listed on our white immunization record or on the client's personal record.  Client had sore arm starting that day, was feeling "back to normal" by 03/27/2009.  No redness or swelling noted.
Received flu vaccine approx 11 AM, at 250 pm patient returned to my office with spotty rash all over body.
About 2 hours after receiving injection he started having tingling of his upper lip and side of his mouth. On 12-13-11 had paralysis on the right side of his face without any slurred speech or other motor s/s or other weakness or neuro s/s.
MOTHER OF PARENTS STATES THAT 1 DAY AFTER INJECTION, DAUGHTER COMPLAINED OF PAIN AT INJECTION SITE. MOTHER STATES THAT SHE NOTICED REDNESS AT SITE WITH "PIMPLE" ON INJECTION SITE. MOTHER STATES SITE IS WARM TO TOUCH. MOTHER STATES THAT CHILD WAS AWAKENED IN TEARS WITH COMPLAINTS OF RT LEG CRAMPS AT APPROX 12:00AM TODAY. STATES THAT CHILD WAS FEELING NAUSEATED TODAY (10/7/10). MOTHER DENIES FEVER.
My son received Influenza vaccine (adult dose) instead of Hepatitis B vaccine. He is now 12 weeks of age. To date, we have not experienced an adverse event. We have no way of knowing if there will be any long term effects.
Chills, fever (highest 102), body aches, sweats. Started in the evening mar 27, then worse overnight into this morning.
About 18 hours later: shortness of breath Throughout the next few days: sharp random pains in chest.
In the patient's words, about 9 hours after the vaccine, he felt cold, achy, and like he had been stabbed with a pole. He said he didn't have any additional breathing trouble. He was fine the next day. Patient had been hospitalized with COVID-19 last summer and was aware that he would most likely have that type of reaction since his body had made B Cells and T Cells to the virus. He was very knowledgeable and kind.
Migraine; Unspecified sickness; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), ILLNESS (Unspecified sickness) and VOMITING (Vomiting) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa.    No Medical History information was reported.   On 14-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced MIGRAINE (Migraine), ILLNESS (Unspecified sickness) and VOMITING (Vomiting). At the time of the report, MIGRAINE (Migraine), ILLNESS (Unspecified sickness) and VOMITING (Vomiting) outcome was unknown.            No concomitant medication was reported.  It was unknown if patient was enrolled in COVID-19 Vaccine Trial.  No treatment information was reported.  The reporter causality for events migraine, unspecified sickness and vomiting with co-suspect Humira was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.